Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.98% | 15.61% | 18.77% | 4.94% | -2.20% |
| Total Depreciation and Amortization | -21.01% | -24.09% | -35.84% | -41.62% | -42.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.04% | -449.60% | -655.28% | -627.07% | -387.16% |
| Change in Net Operating Assets | 561.32% | -92.43% | -64.76% | 169.85% | 2,990.91% |
| Cash from Operations | 24.29% | -9.59% | -3.04% | -9.69% | -12.08% |
| Capital Expenditure | 67.16% | 66.15% | 66.67% | 87.84% | 32.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 67.16% | 66.15% | 66.67% | 87.84% | 32.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.70% | 1.32% | 18.42% | 1.33% | 1.33% |
| Issuance of Common Stock | 6.30% | -13.93% | 11.28% | 159.48% | -28.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -74.65% | -- | -- | -- | -- |
| Cash from Financing | -4.88% | 102.65% | 84.28% | 256.69% | -2.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.19% | 139.37% | 82.35% | 97.40% | -120.93% |